EvaluatePharma is the leader in consensus forecasts of leading industry analysts and analysis of the pharmaceutical and biotechnology healthcare sectors. Information includes sales by indication, licensing deals, merger & acquisitions, venture financing, IPOs, and orphaned drugs.
For more information see the EvaluatePharma Overview page.
Technical Notes:Accounts must be requested from EvaluatePharma. Details available after iMpact login.